Post-intubation iatrogenic tracheobronchial injuries: The state of art

Iatrogenic tracheobronchial injury (ITI) is an infrequent but potentially life-threatening disease, with significant morbidity and mortality rates. Its incidence is presumably underestimated since several cases are underrecognized and underreported. Causes of ITI include endotracheal intubation (EI)...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in surgery Vol. 10; p. 1125997
Main Authors Passera, Eliseo, Orlandi, Riccardo, Calderoni, Matteo, Cassina, Enrico Mario, Cioffi, Ugo, Guttadauro, Angelo, Libretti, Lidia, Pirondini, Emanuele, Rimessi, Arianna, Tuoro, Antonio, Raveglia, Federico
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Iatrogenic tracheobronchial injury (ITI) is an infrequent but potentially life-threatening disease, with significant morbidity and mortality rates. Its incidence is presumably underestimated since several cases are underrecognized and underreported. Causes of ITI include endotracheal intubation (EI) or percutaneous tracheostomy (PT). Most frequent clinical manifestations are subcutaneous emphysema, pneumomediastinum and unilateral or bilateral pneumothorax, even if occasionally ITI can occur without significant symptoms. Diagnosis mainly relies on clinical suspicion and CT scan, although flexible bronchoscopy remains the gold standard, allowing to identify location and size of the injury. EI and PT related ITIs more commonly consist of longitudinal tear involving the pars membranacea. Based on the depth of tracheal wall injury, Cardillo and colleagues proposed a morphologic classification of ITIs, attempting to standardize their management. Nevertheless, in literature there are no unambiguous guidelines on the best therapeutic modality: management and its timing remain controversial. Historically, surgical repair was considered the gold standard, mainly in high-grade lesions (IIIa-IIIb), carrying high morbi-mortality rates, but currently the development of promising endoscopic techniques through rigid bronchoscopy and stenting could allow for bridge treatment, delaying surgical approach after improving general conditions of the patient, or even for definitive repair, ensuring lower morbi-mortality rates especially in high-risk surgical candidates. Our perspective review will cover all the above issues, aiming at providing an updated and clear diagnostic-therapeutic pathway protocol, which could be applied in case of unexpected ITI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Marco Anile, Sapienza University of Rome, Italy
Specialty Section: This article was submitted to Thoracic Surgery, a section of the journal Frontiers in Surgery
Reviewed by: Duilio Divisi, University of L'Aquila, Italy
The manuscript was presented at the XXI SIET National Meeting on Friday 30th September 2022, in Rome, Italy.
ISSN:2296-875X
2296-875X
DOI:10.3389/fsurg.2023.1125997